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ABSTRACT 
The present study was designed to evaluate the hepatoprotective activity of leaves of Santalum album in experimentally 
induced liver injury by carbon tetrachloride and paracetamol. The levels of serum marker enzymes, bilirubin, total protein 
and antioxidant status were determined by measuring lipid peroxidation, glutathione, superoxide dismutase and catalase 
activity. Total wet weight and histopathological study of isolated liver was also carried out.  The oral pre-treatment with 
hydroalcoholic extract of the leaves of S. album (200 and 400 mg/kg) showed significant hepatoprotective activity against 
CCl4 and paracetamol induced hepatotoxicity by decreasing the activities of serum marker enzymes, bilirubin and  lipid 
peroxidation, and significant increase in the levels of glutathione, superoxide dismutase, catalase and protein in a dose 
dependent manner, which was confirmed by the decrease in the total weight of the liver and histopathological examinations. 
Data  also  revealed  that  the  extract  possessed  strong  antioxidant  activity,  which  might  leads  to  the  promising 
hepatoprotective activity. 
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INTRODUCTION 
Excessive production of reactive oxygen species (ROS) plays 
an  important  role  in  the  pathogenesis  and  progression  of 
various  diseases  involving  different  organs. 
[1]  Lipid 
peroxides  produced  from  unsaturated  fatty  acids  via  free 
radicals  cause  toxic  effects  and  promote  the  formation  of 
additional  free  radicals  in  a  chain  reaction.  If  the  in-vivo 
activity  of  enzymes  or  scavengers  is  not  adequate  to 
neutralize these radicals, oxidative stress develops and leads 
to  various  diseases  such  as  cancer,  diabetes  mellitus,  liver 
diseases, brain dysfunction, or accelerated aging may result. 
[2] The rationale for the use of antioxidants is well established 
in  prevention  and  treatment  of  diseases  where  oxidative 
stress plays a major etiopathological role. Antioxidants may 
protect the body against ROS toxicity either by preventing 
the formation of ROS, by the interruption of ROS attack, by 
scavenging the reactive metabolites or by converting them to 
less reactive molecules. 
[3] Therefore the uses of antioxidants, 
both natural and synthetic are gaining wide importance in the 
prevention of various diseases. 
Liver is the vital organ responsible for drug metabolism and  
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appears to be a sensitive target site for substances modulating 
biotransformation. 
[4]  Liver  diseases  are  mainly  caused  by 
toxic  chemicals,  excess  consumption  of  alcohol,  infections 
and  autoimmune  disorders.  Most  of  the  hepatotoxic 
chemicals  damage  liver  cells  mainly  by  inducing  lipid 
peroxidation  and  other  oxidative  stress  in  liver. 
[5]  Carbon 
tetrachloride and paracetamol being converted into reactive 
toxic metabolites by hepatic microsomal cytochrome P-450 
causes hepatotoxicity. 
[6] Among the many diseases that can 
affect the liver, the most common is 'viral hepatitis' and it can 
also  caused  by  drugs,  bacteria,  mushrooms,  parasites  like 
amoebas or giardiasis. About 20,000 deaths found every year 
due  to  liver  disorders. 
[7]  Conventional  or  synthetic  drugs 
used  in  the  treatment  of  liver  diseases  are  sometimes 
inadequate and can have serious adverse effects. 
[8] 
Medicinal  plants  have  been  recognized  and  are  extremely 
valued all over the world as a prosperous source of bioactive 
for the prevention and treatment of ailments. Various plants 
have  been  used  effectively  as  hepatoprotective  agents. 
[9] 
Some of the hepatoprotective plants as well as formulations 
used  in  traditional  medicines  have  been  pharmacologically 
evaluated for their efficacy. However, still more numbers of 
plants are needed to be screened for their hepatoprotective 
potentials.  
One such plant Santalum album Linn (Family: Santalaceae) 
is  locally  available  has  been  used  in  traditional  system  of 
medicine. The wood, root, bark and leaves of the plant used Hegde et al. / Hepatoprotective Potential of Hydroalcoholic Extract of Santalum album…..…… 
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for  the  treatment  of  the  liver  disease  like  jaundice  by  the 
tribal  healers. 
[10]  This  plant  is  very  beneficial  for  treating 
gastric  irritability,  jaundice,  dysentery,  tension  and 
confusion.  Previous  reports  have  proved  that  sandal  wood 
and  root  bark  possessed  abortifacient,  hepatoprotective, 
urinary  antiseptic,  stomachic,  anti-viral  and  anti-herpetic 
activities. 
[11] The leaves of this plant are known to possess 
array  of  flavonoids. 
[12-13]  However,  there  is  paucity  of 
scientific data for the hepatoprotective activities of leaves of 
the plant. On the basis of use of leaves in Ayurveda for the 
treatment of jaundice and the presence of various bioactive 
phytoconstituents  like  flavonoids,  in  the  present  study  an 
attempt is made to evaluate the hepatoprotective activity of 
the plant of S. album Linn leaves. 
 
MATERIALS AND METHODS 
Plant material 
The fresh leaves of Santalum album Linn used for the present 
studies  were  collected  from  Mangalore  in  April  2013  and 
authenticated  by  Mr.  Dinesh  Nayak,  Advisor  (Green  belt), 
Mangalore SEZ Limited. 
Preparation of plant extracts 
The  collected  leaves  material  were  cleaned  to  remove  the 
adhered dust particles and were then shade dried. The dried 
plant materials were coarsely powdered, weighed and stored 
in  an  air  tight  container  till  use.  The  coarse  powder  was 
packed into Soxhlet column and extracted with 70% ethanol 
for about 48 h. The solvent was evaporated using rotary flash 
evaporator to get syrupy consistency. Then the dried extract 
was  stored  in  airtight  container  in  refrigerator  below  8°C 
until used. 
Phytochemical screening  
Freshly prepared hydroalcoholic extract of the leaves of  S. 
album (HASA) was subjected to preliminary phytochemical 
screening for the detection of major chemical constituents. 
[14] 
Experimental animals 
Healthy Wistar albino rats of either sex weighing 150-200 g 
were used. Animals used in the study were procured from 
registered breeder. The animal care and handling was carried 
out  according  to  CPCSEA  guidelines.  Animals  were 
acclimatized to the animal quarantine for one week prior to 
the  experiment  under  controlled  conditions  of  temperature 
(27 ± 2
oC) and were housed in sterile polypropylene cages 
containing paddy husk as bedding material with maximum of 
six animals in each cage. The rats were fed on standard food 
pellets  and  water  ad  libitum.  The  studies  conducted  were 
approved  by  the  Institutional  Animal  Ethical  Committee, 
Srinivas  College  of  Pharmacy,  Mangalore,  Karnataka 
(Approval No.: SCP/CPCSEA/P15/F150/2012). 
Acute toxicity study 
Acute toxicity study of hydroalcoholic extract of the leaves 
of S. album (HASA) was determined in Wistar albino rats 
according to OECD guidelines No. 425. 
[15] The animals were 
fasted overnight and the extract was administered orally with 
a starting dose of 2000 mg/kg, to different animals. Animals 
were observed continuously for first 3 h and monitored for 14 
days for mortality and general behaviour of animals, signs of 
discomfort and nervous manifestations. 
CCl4 -induced hepatotoxicity 
Wistar albino rats were randomly divided in to 5 groups of 6 
animals  each.  Group  I,  the  normal  control  group  was 
administered a single daily dose of 1% Tween 80 (1 ml/kg, 
p.o).  Group  II,  the  toxic  (CCl4)  control  group  was 
administered a single daily dose of 1% Tween 80 (1 ml/kg, 
p.o) and CCl4/olive oil (1:1 v/v, 0.7 ml/kg, i.p) on alternate 
days  for  7  days.  Group  III,  the  standard  group  was 
administered  a  single  daily  dose  of  silymarin  (100  mg/kg, 
p.o) and CCl4/olive oil (1:1 v/v, 0.7 ml/kg, i.p) on alternate 
days  for  7  days.  Group  IV  and  V,  the  test  groups  were 
administered  a  single  daily  dose  of  HASA  (200  and  400 
mg/kg,  p.o,  respectively)  and  CCl4/olive  oil  (1:1  v/v,  0.7 
ml/kg, i.p) on alternate days for 7 days. 
[16] 
Paracetamol induced hepatotoxicity 
The animals were divided in to 5 groups of 6 animals each. 
Group I and II (Normal and toxic) was administered a single 
daily  dose  of  1%  Tween  80  (1  ml/kg,  p.o).  Group  III, 
(standard) was administered a single daily dose of silymarin 
(100  mg/kg,  p.o).  Group  IV  and  V,  the  test  groups  were 
administered  a  single  daily  dose  of  HASA  (200  and  400 
mg/kg,  p.o,  respectively)  for  7  days.  On  5
th  day,  after  the 
administration  of  the  respective  drug  treatments,  all  the 
animals  of  groups  II,  III,  IV  and  V  were  challenged  with 
paracetamol 2 g/kg, p.o, suspended in sucrose solution (40% 
w/v). 
[17] 
Assessment of liver function 
On the seventh day 2 hour after the administration of last 
dose, the animals were sacrificed and blood was withdrawn 
by  intracardiac  puncture  in  both  the  models.  Blood  was 
allowed to clot at room temperature for 30 min, subjected to 
centrifugation (3000 rpm for 15 min). The serum was used to 
estimate serum glutamate oxaloacetate transaminase (SGOT), 
[18]  serum  glutamate  pyruvate  transaminase  (SGPT), 
[19] 
serum  alkaline  phosphatase  (SALP),  total  protein  (TP) 
[20] 
and bilirubin content (total (TB) and direct (DB)). 
[21] The 
liver  was  immediately  isolated  and  washed  with  normal 
saline, blotted with filter paper and weighed. One portion of 
liver  was  subjected  to  histopathological  examination  and 
other  portion  was  subsequently  subjected  to  estimation  of 
endogenous  antioxidant  parameters  like  lipid  peroxidation 
(LPO), 
[22] super oxide dismutase (SOD), glutathione (GSH)
 
[23] and catalase (CAT). 
[24] 
Statistical analysis 
The data were expressed as mean ± SE, (n = 6). Data were 
analyzed  using  One  way  analysis  of  variance  (ANOVA) 
followed  by  Dunnett’s‘t’  test.  Values  of  p<0.05  were 
considered statistically significant. 
 
RESULTS 
Phytochemical screening 
Preliminary  phytochemical  investigation  of  the  HASA 
reveals the presence of  flavonoids, carbohydrates, steroids, 
saponins, glycosides and tannins. 
Acute toxicity study 
Acute toxicity studies were carried out according to OECD 
guidelines. No mortality was observed at 2000 mg/kg body 
weight. Therefore 1/10
th and 1/5
th doses were taken as low 
and high effective dose for the evaluation of hepatoprotective 
activity. 
Effect of HASA on serum biochemical parameters 
Animals  challenged  with  CCl4/paracetamol  (Toxic  control 
group) developed significant liver injury as evident from a 
significant elevation in the biochemical markers like SGPT, 
SGOT, SALP, TP, total bilirubin and direct bilirubin when 
compared with normal control group. Treatment of animals 
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markedly prevented the CCl4/paracetamol induced elevation 
of serum SGPT, SGOT, SALP, bilirubin (total and direct) 
and  increased  the  level  of  total  protein.  Hepatoprotective 
potency of the test extract at the dose 400 mg/kg was found 
closer to that of standard (Table 1). 
Effect of HASA on endogenous antioxidant enzymes 
It was observed that animals treated with CCl4/paracetamol 
developed a hepatic damage, as increase in LPO and decrease 
in GSH, CAT and SOD when compared to normal control 
(Table 2). Animals treated with standard (silymarin) showed 
extremely significant (P<0.001) increase in GSH, CAT, SOD 
and decrease in LPO. Treatment with HASA (200 and 400 
mg/kg,  p.o)  significantly    prevented  the  increase  in  LPO 
levels and brought them near to normal level, whereas GSH, 
SOD  and  CAT  levels  were  significantly    raised,  thus 
providing protection against CCl4/paracetamol toxicities. 
Effect of HASA on liver weight 
The liver weight was increased in CCl4/paracetamol treated 
animals  when  compared  to  normal  control.  The  animals 
which  treated  with  HASA  200  and  400  mg/kg  showed 
significant (P<0.001) decrease in liver weight (Table 2). 
Histopathology 
Histopathological  studies  also  provided  a  supportive 
confirmation  for  biochemical  analysis.  Both  the 
CCl4/paracetamol  intoxicated  groups  of  animals  showed 
inflammation,  centrilobular  degeneration  and  necrosis. 
Treatment with HASA (200 and 400 mg/kg) showed reduced 
inflammation,  centrilobular  and  bridging  necrosis.  Liver 
section  of  these  groups  revealed  normal  hepatocytes  with 
significant reduction in areas of necrosis when compared to 
toxic group. These changes showed protective effect of the 
drug  against  hepatic  damage  induced  by  CCl4/paracetamol 
(Fig.1). 
 
DISCUSSION 
Carbon tetrachloride/paracetamol induced hepatic injuries are 
commonly used models for the screening of hepatoprotective 
drugs and the extent of hepatic damage is assessed by the 
level  of  released  cytoplasmic  alkaline  phosphatase  and 
transaminases  in  circulation.  It  is  well  documented  that 
CCl4/PCM  are  biotransformed  under  the  action  of 
microsomal  cytochrome  P-450  of  liver  to  reactive 
metabolites. 
[25]  These  metabolites  attributed  to  damage 
structural  integrity  of  liver  and  raise  the  levels  of  SGPT, 
SGOT,  ALP  and  bilirubin.  Further  depletion  of  GSH, 
decreased protein synthesis, triglycerides accumulation, and 
increased lipid peroxidation results in hepatocyte damage. 
[26] 
The hepatotoxic effects of CCl4 are largely due to its active 
metabolite,  trichloromethyl  radical  (CCl3
●)  in  presence  of 
cytochrome  P450  which  in  turn  disrupts  the  structure  and 
function  of  lipid  and  protein  macromolecules  in  the 
membrane  of  the  cell  organelles.  Due  to  liver  injury,  the 
transport function of hepatocytes get disturbed, resulting in 
the  leakage  of  plasma  membrane,  thereby  causing  an 
increased enzyme level in serum. While the wet liver weight 
and liver volume was found to be increased, this may be due 
to enlargement of liver cells, accumulation of fluids and fatty 
changes in the liver. CCl4 has important role in reduction of 
intracellular  antioxidant  reduced  glutathione  (GSH), 
increased  LPO,  membrane  damage,  decreased  protein 
synthesis and alteration of hepatic enzymes level. 
The present study revealed a significant alteration in physical 
and biochemical parameter after exposure to the CCl4. The 
plant  extract  HASA  200  and  400  mg/kg  showed  dose 
dependent decrease in the elevated serum biomarkers (SGPT, 
SGOT, SALP and bilirubin) and endogenous enzymes (GSH, 
SOD,  CAT),  it  also  been  observed  that  increase  in  total 
protein  levels  which  were  comparable  to  the  standard  and  
significant reduction in the level of lipid peroxidation.  
Paracetamol  is  metabolized  primarily  in  the  liver  and 
eliminated  by  sulfate  and  glucuronide  conjugation,  and 
excreted by kidney.  
Table 1: Effect of HASA on biochemical parameters in (A) CCl4 and (B) paracetamol induced liver damage in rats 
Groups  Treatment    ALP (U/l)  SGOT (U/l)  SGPT (U/l)  TB (mg/dl)  DB (mg/dl)  T.P (g/dl) 
Normal 
control  1% Tween 80  A  136.3±3.53  86.66±3.04  59.61±1.38  0.945±0.012  0.24±0.009  8.07±0.06 
B  143.3±3.569  74.31±1.759  65.74±1.57  1.01±0.02  0.21±0.01  7.98±0.06761 
Toxic control  CCl4 0.7 ml/kg, i.p  A  359.7±7.06
a  177.4±7.56
a  135.6±2.25
a  2.878±0.018
a  0.54±0.009
a  4.73±0.12
a 
Paracetamol 2 g/kg, p.o  B  307.5±10.35
 a  181.2±9.159
a  147.6±4.48
a  2.44±0.06
a  0.52±0.05
a  5.00±0.13
a 
Standard  Silymarin 
100 mg/kg, p.o 
A  178.4±5.84***  98.32±2.06***  76.74±2.46***  1.120±0.01***  0.27±0.008***  7.70±0.07*** 
B  161.8±3.62***  104.4±3.481***  87.10±2.84***  1.12±0.01***  0.24±0.006***  7.17±0.11*** 
Low dose  HASA 
200 mg/kg, p.o 
A  302.6±4.24***  152.8±1.91**  107.8±1.99***  2.817±0.005**  0.50±0.006**  6.68±0.067*** 
B  261.5±7.502**  141.2±4.140**  123.3±4.20***  2.12±0.03*  0.44±0.03**  6.53±0.050*** 
High dose  HASA 
400 mg/kg, p.o 
A  252.6±4.26***  107.5±3.07***  97.60±2.93***  2.808±0.006**  0.49±0.005**  7.28±0.073*** 
B  225.6±10.60***  118.8±6.98***  100.8±2.815***  1.95±0.15**  0.428±0.02**  6.95±0.07*** 
One way ANOVA followed by Dunnett’s‘t’ test. All the values are Mean±SEM, n=6. 
ap< 0.001 when compared with vehicle treated control group. ns, 
p>0.05,  *p<0.05, **p<0.01, ***p<0.001  when compared with toxic control. 
 
Table 2: Effect of HASA on lipid peroxidation (LPO), superoxide dismutase (SOD), glutathione (GSH), catalase (CAT) and liver weight in (A) CCl4 
and (B) paracetamol induced hepatic damage in rats 
Groups  Treatment    LPO 
(Abs at 535 nm) 
SOD 
(Abs at 560 nm) 
GSH 
(Abs at 412nm) 
CAT 
(Abs at 620 nm)  Liver weight 
Normal 
control  1% Tween 80  A  0.06±0.009  0.83±0.009  0.63±0.009  0.52±0.013  3.53 ±0.06 
B  0.07±0.006  0.88±0.019  0.67±0.01  0.55±0.013  3.48±0.055 
Toxic control  CCl4 0.7 ml/kg, i.p  A  0.35±0.007
a  0.18±0.008
a  0.25±0.009
a  0.25±0.013
a  4.95±0.07
a 
Paracetamo2 g/kg, p.o  B  0.33±0.013
a  0.20±0.02
a  0.33±0.02
a  0.28±0.009
a  5.06±0.07
a 
Standard  Silymarin 
100 mg/kg, p.o 
A  0.15±0.009***  0.65±0.02***  0.54±0.011***  0.42±0.015***  3.72±0.05*** 
B  0.13±0.008***  0.71±0.02***  0.56±0.01***  0.45±0.015***  3.84±0.06*** 
Low dose  HASA 
200 mg/kg, p.o 
A  0.25±0.007***  0.24±0.007*  0.30±0.013**  0.31±0.008**  4.19±0.036*** 
B  0.24±0.012***  0.30±0.01**  0.39±0.007*  0.34±0.012*  4.133±0.05 *** 
High dose  HASA 
400 mg/kg, p.o 
A  0.23±0.008***  0.26±0.006**  0.47±0.010***  0.32±0.011**  3.928±0.054*** 
B  0.20±0.009***  0.31±0.018**  0.41±0.011**  0.36±0.019**  3.90±0.05*** 
One way ANOVA followed by Dunnett’s‘t’ test. All the values are Mean±SEM , n=6. 
ap< 0.001 when compared with vehicle treated control group. ns, 
p>0.05,  *p<0.05, **p<0.01, ***p<0.001  when compared with toxic control. 
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Fig. 1: Effect of Silymarin and HASA on liver histology in CCl4 /Paracetamol induced liver toxicity 
A: Liver of normal rat; B: Liver of CCl4 induced rat; C: Liver treated with silymarin prior to CCl4 administration; D: Liver treated with HASA 200 mg/kg prior 
to CCl4 administration; E: Liver treated with HASA 400 mg/kg prior to CCl4 administration. F: Liver of paracetamol induced rat; G: Liver treated with silymarin 
prior to paracetamol administration; H: Liver treated with HASA 200 mg/kg prior to paracetamol administration; I: Liver treated with HASA 400 mg/kg prior to 
paracetamol administration. 
 
Moreover, paracetamol hepatotoxicity has been attributed to 
the  formation  of  toxic  metabolites,  when  paracetamol  is 
activated by hepatic cytochrome P-450 to a highly reactive 
metabolite  N-acetyl-p-benzoquinoneimine  (NAPQI).  Toxic 
metabolites  (N-acetyl-p-benzoquineimine)  can  alkylate  and 
oxidize  intracellular  GSH,  which  results  in  liver  GSH 
depletion subsequently leads to increased lipid peroxidation 
by  abstracting  hydrogen  from  a  polyunsaturated  fatty  acid 
and  ultimately  liver  damages  due  to  higher  doses  of 
paracetamol. 
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Elevated levels of serum biomarkers are indicative of cellular 
leakage  and  loss  of  functional  integrity  of  hepatic  cell 
membranes  implying  hepatocellular  damage.  Lipid 
peroxidation  has  been  suggested  being  the  destructive 
process  in  liver  injury  due  to  CCl4/paracetamol 
administration.  The  present  study  revealed  a  significant 
alteration  in  physical  and  biochemical  parameter  after 
exposure  to  the  paracetamol. The  plant  extract  HASA-200 
and  HASA-400  showed  dose  dependent  decrease  in  the 
elevated  serum  biomarkers  (SGPT,  SGOT,  ALP  and 
bilirubin)  and  endogenous  enzymes  (GSH,  SOD,  CAT),  it 
also been observed that increase in total proteins levels which 
were comparable to the standard and significant reduction in 
the levels of lipid peroxidation. Hence it might be possible 
that  the  mechanism  of  hepatoprotection  by  hydroalcoholic 
extract is due to its antioxidant potential. 
Protective  effect  in  CCl4  and  paracetamol  induced  liver 
toxicity  was  also  proved  by  decrease  in  relative  organ 
weights in animals treated with both HASA-200 and HASA-
400.  Histopathological  studies  of  liver,  treated  with 
CCl4/paracetamol alone revealed affected the architecture of 
liver parenchyma with damaged hepatocytes. Treatment with 
HASA  (200  and  400  mg/kg)  revealed  the  significant 
improvement  in  architecture  of  liver  parenchyma  and 
regenerating hepatocytes indicating hepatoprotection. 
The  hydroalcoholic  extract  prepared  was  subjected  to 
phytochemical tests and the outcome of these tests revealed 
the presence of carbohydrate, glycosides, flavonoids, tannins, 
steroids and saponins.  
The  number  of  investigators  has  reported  that  flavonoids, 
saponins and other phenolic compounds 
[28, 29] are known to 
possess hepatoprotective activity in animals. It is therefore to 
speculate  that  the  phytoconstituents  present  in  this  plant 
extracts might responsible for the observed hepatoprotective 
activity.  
It  can  be  concluded  from  the  above  data  that  the 
hepatoprotective activity was found to be more significant in 
high  dose  (HASA-400  mg/kg)  compared  to  low  dose 
(HASA-200  mg/kg)  in  both  the  animal  models.  The 
treatment with hydroalcoholic extract of leaves of S. album 
could able to restore the organ (liver) weight at considerable 
range,  which  were  elevated  in  hepatotoxic  animals,  hence 
proving  organ  protective  activity.  The  hepatoprotective 
potential of extract in both the experimental models might be 
due  to  the  presence  of  flavonoids,  saponins  and  other 
polyphenolic  compounds  which  are  attributed  for  the 
antioxidant activity.  
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